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Abstract: Glutathione (GSH) exerts a variety of cytoprotecive effects, but is readily depleted from cells under a variety of stressful
stimuli. The impact of GSH depletion on receptor-mediated activity in rat hepatocytes has been studied with regard to glycogenolysis
stimulated with a-adrenoceptor agonists or glucagon, which exert their actions through different signalling pathways. Depletion of
GSH content (70%) by diethyl maleate had no effect on the redox status of the cells or on basal or glucagon-stimulated
glycogenolysis, but significantly reduced the response to the a-adrenoceptor agonists adrenalin and phenylephrine. These results
highlight the possible modulatory effects of GSH on receptor-mediated activity in hepatocytes.
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Introduction

Materials and Methods

Glutathione (GSH) exerts a variety of cytoprotective
effects, one such being the maintenance of protein thiol
groups in a reduced state, through a role in providing the
reduced milieu required by cells (1,2). This function of
GSH is of particular importance in defence against
oxidative stress. Such protein thiol groups are essential
for the correct functioning of a variety of proteins,
including those involved in receptor-mediated activity.
Whilst modulation of receptor-mediated activity by GSH
has been documented (3-5), there appears to be little
reported in hepatocytes. These cells express a wide range
of receptor-mediated activities, and GSH action is an
important cytoprotective mechanism against a variety of
potentially toxic insults (6).

Adult male Wistar rats (150-180 g) were obtained
from the University of Nottingham Medical School Animal
Unit. They were housed at a constant room temperature
of 22 ºC and had free access to standard laboratory diet
and tap water. Six-well cluster dishes were purchased
from Fahrenheit Laboratory Supplies (Nottingham, U.K.).
Leibowitz L-15 culture medium, adrenaline, glucagon,
phenylephrine, diethyl maleate (DEM), a Trinder glucose
assay kit, MTT, collagen, collagenase and Percoll were
purchased from Sigma Chemical Co. (Poole, Dorset,
U.K.).

We therefore studied the influence of GSH depletion
on the glycogenolytic response of rat hepatocytes to aadrenoceptor agonists and glucagon. Both of these agents
ultimately act to activate glycogen phosphorylase but by
different signalling pathways – an increase in cAMP level
2+
for glucagon and elevation of intracellular Ca by the
adrenoceptor agonists.

Hepatocytes were isolated by perfusion of liver lobes
with collagenase, essentially as described by Reese and
Byard (7). The hepatocyte suspension was washed with
Ca2+-free HEPES buffer, pH 7.4 (136.89 mM NaCl, 5.36
mM KCl, 0.44 mM KH2PO4, 0.38 mM Na2HPO4, 10 mM
NaOH, 20 mM HEPES, and 50 mM phenol red). Cells
were resuspended in Leibowitz L-15 medium and
centrifuged (50 g for 10 min) in a 90% Percoll solution
to improve the separation of viable and nonviable cells, as
described by Kreamer et al. (8). The cell viability, as
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determined by trypan blue exclusion, was typically
greater than 95%. Hepatocytes were suspended in L-15
medium containing 10% v/v calf serum, dispensed into
collagen-coated 6-well plates at a density of 106 cells per
well, and allowed to attach to the substratum for 1-2 h.
Following this attachment period, the medium was
removed and hepatocytes were immediately incubated in
complete HEPES buffer pH 7.4 (composition as before
with the addition of 1.26 mM CaCl2) containing agonists
for 1 h. Alternatively, the cells were exposed to 0.6 mM
DEM for 30 min, after which the cells were washed and
then exposed to the agonists. After the incubation period,
100 ml of medium was assayed for glucose according to
the instructions in the assay kit. Cells were treated with
15% w/v sulphosalicylic acid and the resulting solution
assayed for non-protein thiols by the method suggested
by Saville (9), as described previously (10). The cellular
redox status was determined by MTT reduction as
described by Dhanjal and Fry (11).
Data are presented as mean ± SEM of at least 4-5
experiments. Statistical analysis was undertaken using
unpaired t-tests or analysis of variance with Dunnett’s
post-hoc test as appropriate. A value of P < 0.05 was
considered significant. The EC50 value for adrenalin was
defined as the concentration that produced 50% of the
maximal enhancement of glycogenolysis (determined at
10-5 M).

Results
Treatment of hepatocytes with 0.6 mM DEM led to a
70% reduction in cellular thiol content. This had no
significant effect on the basal level of glycogenolysis or
the level of MTT reduction (Table). Treatment with
-5
glucagon (10 M) caused a significant 3-fold
enhancement in glycogenolysis, which was not modified
by prior GSH depletion (Table).
Treatment with adrenalin produced a concentrationdependent enhancement of glycogenolysis which was
significantly attenuated after GSH depletion at adrenalin
concentrations above 10-9 M (Figure). Despite this, the
EC50 value for adrenalin remained unaltered after GSH
depletion (no depletion 23.0 ± 9.9 nM; with depletion
26.3 ± 15.8 nM; n = 5 rats; P > 0.05).
-5
Phenylephrine (10 M) produced a statistically
significant enhancement of glycogenolysis, this again
being blunted after GSH depletion (Table).

Discussion
As expected, the 3 agonists studied in this work
produced significant enhancement of glycogenolysis.
Adrenalin was more potent than phenylephrine in eliciting
this enhancement, whilst the maximal effects observed
with adrenalin and glucagon were comparable; these

Table. Influence of DEM treatment on hepatocyte thiol content, MTT reduction, and levels of
basal and agonist-stimulated glycogenolysis.
Variable

Untreated Cells

DEM-Treated Cells

Thiol content (nmol/well)

36.0 ± 1.6

10.3 ± 0.5*

MTT reduction (absorbance)

0.16 ± 0.01

0.16 ± 0.01

0.14 ± 0.01

0.16 ± 0.01

3.06 ± 0.21

2.71 ± 0.11

1.94 ± 0.29

1.60 ± 0.20*

Glycogenolysis:
Basal
(mg glucose released per well in 30 min)
Stimulated with glucagon (10-5 M)
(fold increase above basal)
Stimulated with phenylephrine (10-5 M)
(fold increase above basal)

Values are mean ± SEM of 4-5 separate animals
* Where indicated, values for DEM-treated cells are significantly different from those incubated
without DEM treatment (P < 0.05 or less; paired t-test).
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Glycogenolysis (% of control)
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*
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Log [adrenalin] (M)

-6

-5

Figure. Influence of DEM treatment on adrenalin-stimulated
glycogenolysis in rat isolated hepatocytes. Values are mean ±
SEM of 5 separate animals.
* Where indicated, values for DEM-treated cells are significantly
different from those incubated without DEM treatment (P < 0.05 or
less).

findings are in agreement with those of other researchers
(12,13).
Treatment with DEM (0.6 mM) produced the
expected marked depletion of GSH, which was not
associated with a gross alteration in the cellular redox
status as determined by MTT reduction. GSH depletion
did not impair the basal level of glycogenolysis, but did
cause a reduced effect of adrenalin on glycogenolysis, as
manifested by a reduction in the maximum response with
no change in the EC50 value. Krack and et al. (14)
demonstrated that DEM at a concentration of 0.9 mM by
itself caused a fall in hepatocyte glycogen content.
However, it seems unlikely that the reduced response to
adrenalin after DEM treatment could be ascribed to a
reduction in glycogen content, as the effect of glucagon,
which was comparable to that of the highest
concentration of adrenalin, was not modified by this
treatment. This, together with the lack of effect of DEM
treatment on basal glycogenolysis, suggests that the
reduction in adrenalin responsiveness after DEM
treatment is not mediated directly on the enzymic
pathways involved in glycogen breakdown. In the adult
rat, adrenalin stimulates hepatic glycogenolysis via a1-

adrenoceptors, and the finding that the stimulatory
effects
of
another
a1-adrenoceptor
agonist,
phenylephrine, are also attenuated after GSH depletion
points to a selective modification of adrenoceptor activity
by GSH depletion in rat hepatocytes. These observations
are consistent with evidence for the involvement of thiol
groups in the binding site of a1-adrenoceptors in the
cerebral cortex (15).
Evidence for the presence of multiple reactive thiol
groups in the glucagon-sensitive adenyl cyclase system
has also been presented (16), but GSH depletion had no
significant effect on glucagon-stimulated glycogenolysis
(Table). As part of their studies, Lipson et al. (16) also
reported that the basal adenyl cyclase activity showed
greater sensitivity to thiol alkylation than did the
glucagon-sensitive form. Given that basal glycogenolysis
was unaffected by GSH depletion in the present study, it
is thus possible that the extent of this depletion was
insufficient to modify the thiol groups important for
glucagon-stimulated glycogenolysis.
It is well known that adrenalin is released into the
plasma in response to stress (17), and adrenalin has been
reported to inhibit hepatic GSH synthesis (18,2). In the
light of these observations, the present findings point to
a mechanism whereby the ability of the liver to respond
to stress by increasing glucose output mediated by
adrenalin is limited by the concomitant GSH depletion. It
is also known that hepatic GSH levels are modulated by
dietary status and exposure to a variety of toxic chemicals
(6,19), and these may also impinge upon the adrenalinmediated stimulation of glycogenolysis. In a broader
context, the present findings provide further evidence for
the importance of GSH status in regulating receptormediated activity.
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